Cargando…

Levosimendan for VA‐ECMO weaning: the silver lining

Detalles Bibliográficos
Autores principales:	Kaddoura, Rasha, Mohamed Ibrahim, Mohamed Izham, Omar, Amr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788139/ https://www.ncbi.nlm.nih.gov/pubmed/34873878 http://dx.doi.org/10.1002/ehf2.13751

Ejemplares similares

Postcardiotomy VA-ECMO for refractory cardiogenic shock
por: Charlesworth, Michael, et al.
Publicado: (2017)

Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients
por: Elsherbini, Hagar, et al.
Publicado: (2021)

Correction to: Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients
por: Elsherbini, Hagar, et al.
Publicado: (2021)

Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial
por: Ellouze, Omar, et al.
Publicado: (2021)

De-adoption of oral chlorhexidine for mechanically ventilated patients: get thee to a conclusion
por: Omar, Amr S, et al.
Publicado: (2022)

Insight into appropriate medication prescribing for elderly in the COVID-19 era
por: Omar, Amr S, et al.
Publicado: (2022)

Predictors of weaning failure in case of VA ECMO implantation
por: Cusanno, Axelle, et al.
Publicado: (2022)

Fulminant myocarditis in COVID-19 and favorable outcomes with VA-ECMO
por: Bhardwaj, Abhishek, et al.
Publicado: (2022)

Intracoronary pharmacological therapy versus aspiration thrombectomy in STEMI (IPAT-STEMI): A systematic review and meta-analysis of randomized trials
por: Kaddoura, Rasha, et al.
Publicado: (2022)

Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Functional evaluation of sublingual microcirculation indicates successful weaning from VA-ECMO in cardiogenic shock
por: Akin, Sakir, et al.
Publicado: (2017)

Correction to: Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Surgical pulmonary embolectomy on VA-ECMO
por: Steinhorn, Rachel, et al.
Publicado: (2021)

Neonatal VA ECMO: Why and how?
por: Mendonca, Malaika
Publicado: (2017)

Refractory vasodilatory shock secondary to metformin overdose supported with VA ECMO()
por: Ives Tallman, Crystal, et al.
Publicado: (2021)

Levosimendan use in the emergency management of decompensated peripartum cardiomyopathy
por: Uriarte-Rodríguez, Alina, et al.
Publicado: (2010)

Microcirculatory assessment of patients under VA-ECMO
por: Kara, Atila, et al.
Publicado: (2016)

LV distention on VA-ECMO, what to do?
por: Pappalardo, Federico, et al.
Publicado: (2017)

Growing Evidence for LV Unloading in VA ECMO
por: Soltes, Jan, et al.
Publicado: (2023)

Levosimendan improves the acute course of takotsubo syndrome: a pooled analysis
por: Jaguszewski, Milosz J., et al.
Publicado: (2021)

Role of VA ECMO in septic shock: Does it work?
por: Combes, Alain
Publicado: (2017)

A case study of Harlequin syndrome in VA-ECMO
por: Al Hanshi, Said Ali Masoud, et al.
Publicado: (2017)

Predicting clinical outcome in patients undergoing VA-ECMO
por: Kimmoun, Antoine, et al.
Publicado: (2019)

Recurrent Silicone Embolism Syndrome requiring VA ECMO
por: Madan, Nikhil, et al.
Publicado: (2022)

Hidden Harlequin syndrome in neonatal and pediatric VA-ECMO
por: Levy, Yael, et al.
Publicado: (2022)

ECMO and endogenous carboxyhemoglobin formation
por: Tripathi, Ravi S, et al.
Publicado: (2011)

Multiparameters Associated to Successful Weaning from VA ECMO in Adult Patients with Cardiogenic Shock or Cardiac Arrest: Systematic Review and Meta-Analysis
por: Burgos, Lucrecia María, et al.
Publicado: (2023)

What is New in ECMO for COVID-19?
por: Furzan, Alberto, et al.
Publicado: (2023)

Normalizing the Abnormal: Hypoxemia in Venovenous ECMO
por: Ortoleva, Jamel P., et al.
Publicado: (2022)

Modalities of Left Ventricle Decompression during VA-ECMO Therapy
por: Ricarte Bratti, Juan Pablo, et al.
Publicado: (2021)

Predictors of survival in VA-ECMO: Whom should we cannulate?
por: Lorusso, Roberto
Publicado: (2017)

Procedural volume and outcomes in patients undergoing VA-ECMO support
por: Becher, Peter Moritz, et al.
Publicado: (2020)

Performing cardiac investigations after VA ECMO implementation in adults
por: Barrett, Nicholas A
Publicado: (2019)

Extracorporeal Membrane Oxygenation (VA-ECMO) in Management of Cardiogenic Shock
por: Koziol, Klaudia J., et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Haemodynamic effects of levosimendan in patients during weaning from cardiopulmonary bypass
por: Demeyere, R, et al.
Publicado: (2002)

Factors associated with hemolysis during extracorporeal membrane oxygenation (ECMO)—Comparison of VA- versus VV ECMO
por: Appelt, Hannah, et al.
Publicado: (2020)

Characterization of Cerebral Hemodynamics with TCD in Patients Undergoing VA-ECMO and VV-ECMO: a Prospective Observational Study
por: Caturegli, Giorgio, et al.
Publicado: (2022)

Echocardiography and impedance cardiography as determinants of successful slow levosimendan infusion in advanced older heart failure patients
por: Ruocco, Gaetano, et al.
Publicado: (2021)

Can VA-ECMO Be Used as an Adequate Treatment in Massive Pulmonary Embolism?
por: Giraud, Raphaël, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ltk955mr3f6s1icsl9sh18r7ap